Recent News for HTBX - Heat Biologics, Inc.

Date Title
May 29 Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
May 29 The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
May 28 ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'
May 27 Heat Biologics partners with Wisconsin University on COVID-19 vaccine
May 27 Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
May 18 We're Keeping An Eye On Heat Biologics's (NASDAQ:HTBX) Cash Burn Rate
May 15 Heat Biologics reports Q1 results
May 15 Heat Biologics Provides First Quarter 2020 Business Update
May 15 20 Healthcare Stocks Moving In Friday's Pre-Market Session
May 14 Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
May 11 Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110
Apr 29 Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones
Apr 24 32 Stocks Moving in Friday's Pre-Market Session
Apr 23 Heat Biologics files for $150M mixed shelf; shares down 8% after hours
Apr 14 31 Stocks Moving in Tuesday's Pre-Market Session
Apr 13 Coronavirus: Trump retweets call to fire Fauci
Apr 11 Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
Apr 9 HTBX: $25M in Cash to Advance Portfolio
Apr 1 Heat Biologics Announces Formation of COVID-19 Advisory Board
Mar 30 Heat Biologics Provides Year-End Business Update
Mar 26 31 Stocks Moving in Thursday's Pre-Market Session
Mar 23 Morrisville firm developing coronavirus test that produces results in 30 minutes
Mar 23 Healthcare firms announce Covid-19-related actions
Mar 23 Heat Biologics and University of Miami Developing Proprietary COVID-19 Diagnostic Test Under Collaborative Research Agreement
Mar 19 Profit-taking pressures Moderna after Hahn comments on vaccine timeline

Back to the Main HTBX Page...